Intuitive Surgical, Inc. (NASDAQ:ISRG)‘s stock had its “outperform” rating reaffirmed by analysts at Leerink Swann in a research note issued on Wednesday, July 5th.
ISRG has been the subject of several other reports. BidaskClub raised Intuitive Surgical from a “buy” rating to a “strong-buy” rating in a research report on Friday, June 23rd. Zacks Investment Research lowered Intuitive Surgical from a “buy” rating to a “hold” rating in a research report on Tuesday, June 20th. Cantor Fitzgerald initiated coverage on Intuitive Surgical in a report on Thursday, June 29th. They issued a “neutral” rating and a $1,000.00 price objective for the company. Bank of America Corporation reissued a “buy” rating and issued a $1,000.00 price objective on shares of Intuitive Surgical in a report on Thursday, June 1st. Finally, Canaccord Genuity lowered Intuitive Surgical from a “buy” rating to a “hold” rating and set a $870.00 price objective for the company. in a report on Tuesday, May 30th. They noted that the move was a valuation call. Six equities research analysts have rated the stock with a hold rating, thirteen have given a buy rating and one has issued a strong buy rating to the stock. Intuitive Surgical currently has a consensus rating of “Buy” and an average target price of $980.03.
Shares of Intuitive Surgical (NASDAQ:ISRG) traded up 1.00% during mid-day trading on Wednesday, hitting $941.20. 487,001 shares of the stock traded hands. Intuitive Surgical has a 52 week low of $610.71 and a 52 week high of $974.66. The stock has a 50-day moving average of $937.40 and a 200-day moving average of $815.32. The company has a market cap of $34.97 billion, a price-to-earnings ratio of 45.08 and a beta of 0.39.
Intuitive Surgical (NASDAQ:ISRG) last released its earnings results on Thursday, July 20th. The medical equipment provider reported $5.95 earnings per share for the quarter, beating analysts’ consensus estimates of $5.79 by $0.16. The business had revenue of $756.20 million during the quarter, compared to the consensus estimate of $724.51 million. Intuitive Surgical had a net margin of 28.44% and a return on equity of 15.99%. The company’s revenue for the quarter was up 12.8% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $5.62 EPS. Analysts anticipate that Intuitive Surgical will post $23.86 EPS for the current year.
COPYRIGHT VIOLATION NOTICE: This piece was originally published by Chaffey Breeze and is owned by of Chaffey Breeze. If you are viewing this piece on another website, it was stolen and republished in violation of United States and international trademark and copyright law. The legal version of this piece can be accessed at https://www.chaffeybreeze.com/2017/07/30/intuitive-surgicals-nasdaqisrg-outperform-rating-reaffirmed-at-leerink-swann-updated-updated-updated.html.
In other Intuitive Surgical news, Director Amal M. Johnson sold 1,000 shares of the stock in a transaction dated Wednesday, May 31st. The stock was sold at an average price of $917.27, for a total value of $917,270.00. Following the transaction, the director now owns 3,787 shares of the company’s stock, valued at $3,473,701.49. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, SVP Curet Myriam sold 1,202 shares of the stock in a transaction dated Tuesday, July 25th. The stock was sold at an average price of $950.20, for a total value of $1,142,140.40. Following the sale, the senior vice president now owns 1,428 shares of the company’s stock, valued at approximately $1,356,885.60. The disclosure for this sale can be found here. Insiders have sold 37,498 shares of company stock worth $34,533,846 over the last three months. Insiders own 2.50% of the company’s stock.
Several hedge funds have recently added to or reduced their stakes in the company. Guardian Life Insurance Co. of America boosted its position in Intuitive Surgical by 2.2% in the first quarter. Guardian Life Insurance Co. of America now owns 142 shares of the medical equipment provider’s stock valued at $109,000 after buying an additional 3 shares in the last quarter. Greenleaf Trust raised its stake in shares of Intuitive Surgical by 0.8% in the first quarter. Greenleaf Trust now owns 477 shares of the medical equipment provider’s stock worth $366,000 after buying an additional 4 shares during the period. Dynamic Advisors Solutions LLC raised its stake in shares of Intuitive Surgical by 0.6% in the first quarter. Dynamic Advisors Solutions LLC now owns 905 shares of the medical equipment provider’s stock worth $694,000 after buying an additional 5 shares during the period. Bronfman E.L. Rothschild L.P. raised its stake in shares of Intuitive Surgical by 1.8% in the first quarter. Bronfman E.L. Rothschild L.P. now owns 280 shares of the medical equipment provider’s stock worth $215,000 after buying an additional 5 shares during the period. Finally, Miles Capital Inc. raised its stake in shares of Intuitive Surgical by 1.3% in the first quarter. Miles Capital Inc. now owns 566 shares of the medical equipment provider’s stock worth $434,000 after buying an additional 7 shares during the period. Hedge funds and other institutional investors own 97.56% of the company’s stock.
Intuitive Surgical Company Profile
Intuitive Surgical, Inc (Intuitive) designs, manufactures and markets da Vinci Surgical Systems, and related instruments and accessories. The Company’s da Vinci Surgical System consists of a surgeon’s console, a patient-side cart and a vision system. The da Vinci Surgical System translates a surgeon’s hand movements, which are performed on instrument controls at a console, into corresponding micro-movements of instruments positioned inside the patient through small incisions or ports.
Receive News & Ratings for Intuitive Surgical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical Inc. and related companies with MarketBeat.com's FREE daily email newsletter.